IDH mutation promotes tumorigenesis by affecting cell metabolism and its microenvironment, and IDH-mutant gliomas are associated with lower grade and favorable survival (Berzero et al., 2021; Hartmann et al., 2010). Here, IDH1 is linked to central nervous system cancer.